These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9661650)

  • 21. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
    Ito T; Yasue H; Yoshimura M; Nakamura S; Nakayama M; Shimasaki Y; Harada E; Mizuno Y; Kawano H; Ogawa H
    Hum Genet; 2002 Jan; 110(1):89-94. PubMed ID: 11810302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
    Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
    Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus.
    Murata M; Maruyama T; Suzuki Y; Saruta T; Ikeda Y
    Diabet Med; 2004 Aug; 21(8):837-44. PubMed ID: 15270786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
    Aubó C; Sentí M; Marrugat J; Tomás M; Vila J; Sala J; Masiá R
    Eur Heart J; 2000 Jan; 21(1):33-8. PubMed ID: 10610741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus.
    Odawara M; Tachi Y; Yamashita K
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2257-60. PubMed ID: 9215303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gln --> Arg 191 polymorphism of paraoxonase and Parkinson's disease.
    Akhmedova S; Anisimov S; Yakimovsky A; Schwartz E
    Hum Hered; 1999 Jun; 49(3):178-80. PubMed ID: 10364684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides.
    Singh S; Kumar V; Thakur S; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Ichhpujani RL; Rai A
    Toxicol Appl Pharmacol; 2011 Apr; 252(2):130-7. PubMed ID: 21291901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
    Inoue M; Suehiro T; Nakamura T; Ikeda Y; Kumon Y; Hashimoto K
    Metabolism; 2000 Nov; 49(11):1400-5. PubMed ID: 11092501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes.
    Gallego PH; Craig ME; Duffin AC; Bennetts B; Jenkins AJ; Hofer S; Lam A; Donaghue KC
    Diabetes Care; 2008 Aug; 31(8):1585-9. PubMed ID: 18469206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy.
    Mansfield MW; Stickland MH; Carter AM; Grant PJ
    Thromb Haemost; 1994 Jun; 71(6):731-6. PubMed ID: 7974340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.
    Ikeda Y; Suehiro T; Inoue M; Nakauchi Y; Morita T; Arii K; Ito H; Kumon Y; Hashimoto K
    Metabolism; 1998 May; 47(5):598-602. PubMed ID: 9591753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.
    Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Karpe J; Kajdaniuk D; Głogowska-Szelag J; Nowak K
    Clin Exp Med; 2010 Sep; 10(3):185-92. PubMed ID: 20012460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus.
    Demaine A; Cross D; Millward A
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4064-8. PubMed ID: 11095596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.
    Antikainen M; Murtomäki S; Syvänne M; Pahlman R; Tahvanainen E; Jauhiainen M; Frick MH; Ehnholm C
    J Clin Invest; 1996 Aug; 98(4):883-5. PubMed ID: 8770857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
    Ruiz J; Blanché H; James RW; Garin MC; Vaisse C; Charpentier G; Cohen N; Morabia A; Passa P; Froguel P
    Lancet; 1995 Sep; 346(8979):869-72. PubMed ID: 7564671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of paraoxonase (PON1) status requires more than genotyping.
    Richter RJ; Furlong CE
    Pharmacogenetics; 1999 Dec; 9(6):745-53. PubMed ID: 10634137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene.
    Sentí M; Aubó C; Elosua R; Sala J; Tomás M; Marrugat J
    Genet Epidemiol; 2000 Mar; 18(3):276-86. PubMed ID: 10723110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.